Beyond LDL-C: Precision Approaches to Residual Risk With Drs. James Underberg and Martha Gulati

This activity is supported by independent educational grants from Arrowhead Pharmaceuticals, Inc.; Chiesi USA, Inc.; Cleerly Health; Esperion Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.


0.50CME
0.50ABIM MOC
30MINS
H761_MET003_1200x630.png

Already listened on another platform?

Overview

Provider Statement

This continuing education activity is provided by

 

Support Statement

This activity is supported by independent educational grants from Arrowhead Pharmaceuticals, Inc.; Chiesi USA, Inc.; Cleerly Health; Esperion Therapeutics, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.

Activity Description

In this episode, Drs Underberg and Wright review updated guidelines for managing elevated LDL-C and the role of non-statin lipid-lowering therapies in achieving LDL-C targets.

Target Audience

The intended audience for this activity is physicians specializing in cardiology, lipidology, or primary care and allied health professionals involved in the management of patients with dyslipidemia.

Learning Objectives

Upon successful completion of this activity, participants should be better able to assess residual ASCVD risk beyond LDL-C using novel risk assessment technologies.

Activity Chair

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Clinical Assistant Professor of Medicine
NYU School of Medicine & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
Past-President, National Lipid Association
Past-President, American Board of Clinical Lipidology
Diplomate, American Board of Clinical Lipidology
New York, NY

Faculty

Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon)
Director, Davis Women's Heart Center
Professor of Medicine & Cardiology
Davis Women's Heart Endowed Chair
Department of Cardiology
Houston Methodist Debakey Heart & Vascular Center
Houston, TX

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP


Accreditation

ACCME Jointly accredited  In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

abimSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

This enduring material is approved for 1 year from the date of original release, November 15, 2026, to November 14, 2027.

How to Participate in This Activity and Obtain CE Credit

To participate in this activity, you must read the objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 100% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.

In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible companies. All relevant financial relationships with ineligible companies have been mitigated prior to the commencement of the activity.

Activity Chair and Faculty report the following relevant financial relationship(s)

James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA
Consultant: Amgen
Speaker Contracted by Ineligible Company: Amgen, Esperion Regeneron
Independent Research Contractor: Chiesi
Individual Stocks (publicly traded): Arrowhead, NewAmsterdam

Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon)

Advisor: Amgen, Bayer, Boehringer Ingelheim, Regeneron
Speaker Contracted by Ineligible Company: Zoll
Data Safety Monitoring Board: Merck
Principal Investigator: AstraZeneca

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Accessibility

Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners. Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.

Copyright Statement

Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

CE Questions?

Contact us at cme@vindicoCME.com